Yahoo Web Search

  1. Antares Pharma Inc (ATRS) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 06 21:23 PM

    Factors that could cause actual results to differ include, but are not limited to, market acceptance, adequate reimbursement successful launch and future revenue from XYOSTED and Antares ...

  2. We've also continued to make great progress preparing for our planned...

  3. The company has a market cap of $9.20 billion. Thanks to the encouraging factors, this Zacks Rank #3 (Hold) company is still worth holding onto. Market Access Expansion Continues ...

  4. GW Pharmaceuticals (GWPH) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 09 18:47 PM

    Justin D. Gover -- Chief Executive Officer and Executive Director Thank you, Scott. In closing, we continue to be very excited about the U.S. launch experience with Epidiolex to date. With all ...

  5. AcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 06 1:24 AM

    I would like to now turn the call over to Raffi Asadorian, AcelRx's Chief Financial Officer. With me today, are Vince Angotti, our Chief Executive Officer and Dr. Pam Palmer, our Chief Medical ...

  6. Cryoport (CYRX) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 10 3:23 AM

    Before we begin today, I would like to remind everyone that this conference call contains certain forward-looking statements. All statements that address our operating performance, events or ...

  7. I will now turn the call over to Maria Stahl, Chief Business Officer. Chris will provide an overview on our second quarter 2019 financial results.

  8. Acceleron Pharma Inc (XLRN) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 06 15:23 PM

    This cash balance includes the receipt of a $25 million gross milestone payment earned upon acceptance of the luspatercept BLA and MAA filings. This compares to December 31, 2018 cash ...

  9. UroGen Pharma Ltd. (URGN) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 12 20:23 PM

    Thank you for standing by, and welcome to UroGen Pharma's Second Quarter 2019 Financial Results and Business Update Conference Call. It is now my pleasure to turn the call over to Kate Bechtold ...

  10. Bloom Energy Corporation (BE) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 13 5:23 AM

    I would now like to turn the conference over to Mark Mesler, vice president of finance and investor relations at Bloom Energy. Good afternoon all, and thank you for joining us on Bloom Energy's ...